Article
Prognostic significance of interleukin-6 single nucleotide polymorphism genotypes in neuroblastoma: rs1800795 (promoter) and rs8192284 (receptor).
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Aug 2009
Lagmay Joanne P, London Wendy B, Gross Thomas G, Termuhlen Amanda, Sullivan Nicholas, Axel Amy, Mundy Bethany, Ranalli Mark, Canner Jason, McGrady Patrick, Hall Brett
Abstract excerpt
PURPOSE: Neuroblastoma is a childhood cancer of the sympathetic nervous system and many patients present with high-risk disease. Risk stratification, based on pathology and tumor-derived biomarkers, has improved prediction of clinical outcomes, but overall survival (OS) rates remain unfavorable and new therapeutic targets are needed. Some studies suggest a link between interleukin (IL)-6 and more aggressive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
